Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ekaterina Korchevaya"'
Autor:
Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Grigory Glukhov, Olga Sokolova, Roman Samoilikov, Vitaly Zverev
Publikováno v:
International Journal of Biomedicine, Vol 11, Iss Suppl_1, Pp 31-32 (2021)
Background: Vaccination is the most effective tool for reducing the morbidity and mortality of COVID-19. Particular interest is the development of whole-virion inactivated vaccines, since such vaccines include a complete set of viral structural prote
Externí odkaz:
https://doaj.org/article/f7e7bdbfffad40759133800c5eee901a
Autor:
Irina Leneva, Nadezhda Kartashova, Artem Poromov, Anastasiia Gracheva, Ekaterina Korchevaya, Ekaterina Glubokova, Olga Borisova, Anna Shtro, Svetlana Loginova, Veronika Shchukina, Ravil Khamitov, Evgeny Faizuloev
Publikováno v:
Viruses, Vol 13, Iss 8, p 1665 (2021)
An escalating pandemic of the novel SARS-CoV-2 virus is impacting global health, and effective antivirals are needed. Umifenovir (Arbidol) is an indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and o
Externí odkaz:
https://doaj.org/article/a6576c79bebb4455bd5cf34ea143ca6b
Autor:
Ekaterina Korchevaya, Tatiana Zaytseva, Alexander Poddubikov, Evgeny Faizuloev, Evgenij Pashkov
Publikováno v:
Sanitarnyj vrač (Sanitary Doctor). :65-74
Influenza is a widespread respiratory infection, accompanied by damage to the lower respiratory tract of a person, and can lead to severe complications, up to a fatal outcome. Currently existing therapeutic agents and vaccines do not provide fully ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69c956b0276bb5c994a3e8675991df33
https://doi.org/10.33920/med-08-2201-07.
https://doi.org/10.33920/med-08-2201-07.
Autor:
Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Daria Smirnova, Roman Samoilikov, Andrey Pankratov, Galina Trunova, Varvara Khokhlova, Yulia Ammour, Olga Petrusha, Artem Poromov, Irina Leneva, Oxana Svitich, Vitaly Zverev
Publikováno v:
Vaccine.
As novel SARS-CoV-2 Variants of Concern emerge, the efficacy of existing vaccines against COVID-19 is declining. A possible solution to this problem lies in the development of a live attenuated vaccine potentially able of providing cross-protective a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8df0b5f0d860a3ba945bca4507d0a92
https://pubmed.ncbi.nlm.nih.gov/36528447
https://pubmed.ncbi.nlm.nih.gov/36528447
Autor:
Evgeny Pashkov, Ekaterina Korchevaya, Evgeny Faizuloev, Artem Rtishchev, Bogdan Cherepovich, Elizaveta Bystritskaya, Alexander Sidorov, Alexander Poddubikov, Anatoly Bykov, Yuliya Dronina, Oxana Svitich, Vitaliy Zverev
Publikováno v:
Infectious disorders drug targets. 22(5)
Background: Influenza is one of the most common infectious diseases, which affect the lower respiratory tract, and can lead to serious complications including death. It is known that currently available therapeutic agents and vaccines do not provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1bc20eb268da90b57f230e927b6f919
https://pubmed.ncbi.nlm.nih.gov/35339191
https://pubmed.ncbi.nlm.nih.gov/35339191
Autor:
Victor Volok, Ekaterina Korchevaya, E. B. Faizuloev, Georgy Ignatyev, Ravil Khamitov, Artem Poromov, V. N. Shchukina, Nadezhda P. Kartashova, Irina A. Leneva, Anastasya Gracheva, Svetlana Loginova, Liubov I. Kozlovskaya
Publikováno v:
Clinical problems.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0bbc171f878013264cbc94281b3d401
https://doi.org/10.1183/13993003.congress-2021.oa2660
https://doi.org/10.1183/13993003.congress-2021.oa2660
Autor:
Anastasiia Gracheva, E. B. Faizuloev, Roman Samoilikov, Zverev Vv, Olga Sokolova, Ekaterina Korchevaya, G. S. Glukhov
Publikováno v:
International Journal of Biomedicine, Vol 11, Iss Suppl_1, Pp 31-32 (2021)
Background: Vaccination is the most effective tool for reducing the morbidity and mortality of COVID-19. Particular interest is the development of whole-virion inactivated vaccines, since such vaccines include a complete set of viral structural prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2768dbb847f4f6ba517066c034173c
https://doi.org/10.21103/ijbm.11.suppl_1.p44
https://doi.org/10.21103/ijbm.11.suppl_1.p44
Autor:
Nadezhda P. Kartashova, Irina A. Leneva, Anastasiia Gracheva, Ravil Khamitov, E. B. Faizuloev, V. N. Shchukina, Svetlana Loginova, Artem Poromov, Ekaterina A Glubokova, Olga V. Borisova, Ekaterina Korchevaya, Anna Shtro
Publikováno v:
Viruses
Volume 13
Issue 8
Viruses, Vol 13, Iss 1665, p 1665 (2021)
Volume 13
Issue 8
Viruses, Vol 13, Iss 1665, p 1665 (2021)
An escalating pandemic of the novel SARS-CoV-2 virus is impacting global health, and effective antivirals are needed. Umifenovir (Arbidol) is an indole-derivative molecule, licensed in Russia and China for prophylaxis and treatment of influenza and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67fba74130d1612870522d1ea90df4e
https://doi.org/10.3390/v13081665
https://doi.org/10.3390/v13081665